Ken Griffin Avanos Medical, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$17.85 - $20.42 $55,335 - $63,302	-3,100 Reduced 79.49%	800 $15,000
Q1 2024 May 15, 2024	SELL	$17.97 - $22.68 $68,286 - $86,184	-3,800 Reduced 49.35%	3,900 $77,000
Q4 2023 Feb 14, 2024	BUY	$17.64 - $22.99 $102,312 - $133,342	5,800 Added 305.26%	7,700 $172,000
Q3 2023 Nov 14, 2023	BUY	$19.93 - $26.31 $11,958 - $15,786	600 Added 46.15%	1,900 $38,000
Q2 2023 Aug 14, 2023	SELL	$22.53 - $30.98 $45,060 - $61,960	-2,000 Reduced 60.61%	1,300 $33,000
Q1 2023 May 15, 2023	BUY	$26.92 - $31.75 $21,536 - $25,400	800 Added 32.0%	3,300 $98,000
Q4 2022 Feb 14, 2023	BUY	$19.88 - $27.37 $49,700 - $68,425	2,500 New	2,500 $67,000

272

41.8M

800

9.2K

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $950M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.